The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update
Open accessAbstract
The vascular endothelium is a dynamic, functionally complex organ, modulating multiple biological processes, including vascular tone and permeability, inflammatory responses, thrombosis, and angiogenesis. Endothelial dysfunction is a threat to the integrity of the vascular system, and it is pivotal in the pathogenesis of atherosclerosis and cardiovascular disease. Reduced nitric oxide (NO) bioavailability is a hallmark of chronic kidney disease (CKD), with this disturbance being almost universal in patients who reach the most advanced phase of CKD, end-stage kidney disease (ESKD). Low NO bioavailability in CKD depends on several mechanisms affecting the expression and the activity of endothelial NO synthase (eNOS). Accumulation of endogenous inhibitors of eNOS, inflammation and oxidative stress, advanced glycosylation products (AGEs), bone mineral balance disorders encompassing hyperphosphatemia, high levels of the phosphaturic hormone fibroblast growth factor 23 (FGF23), and low levels of the active form of vitamin D (1,25 vitamin D) and the anti-ageing vasculoprotective factor Klotho all impinge upon NO bioavailability and are critical to endothelial dysfunction in CKD. Wide-ranging multivariate interventions are needed to counter endothelial dysfunction in CKD, an alteration triggering arterial disease and cardiovascular complications in this high-risk population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–217 of 217
Tripepi, G. L., Kollerits, B., Leonardis, D., Yilmaz, M. I., Postorino, M., Fliser, D., Mallamaci, F., Kronenberg, F., & Zoccali, C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121355 · Cited by 27
Self-citationAsymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia
Yokoro, M., Nakayama, Y., Yamagishi, S., Ando, R., Sugiyama, M., Ito, S., Yano, J., Taguchi, K., Kaida, Y., Saigusa, D., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111184 · Cited by 27
Çoban, M., İnci, A., Yılmaz, Ü., & Asiltürk, E. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000492244 · Cited by 26
Improvement of Endothelial function by Amlodipine and Vitamin C in Essential Hypertension
On, Y. K., Kim, C., Sohn, D. W., Oh, B., Lee, M. M., Park, Y. B., & Choi, Y. S. (2002) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2002.17.2.131 · Cited by 25
Gamboa, J. L., Pretorius, M., Sprinkel, K. C., Brown, N. J., & Ikizler, T. A. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0162-x · Cited by 25
Cui, W., Leng, B., Liu, W., & Wang, G. (2018) · Medical Science Monitor · doi:10.12659/msm.911202 · Cited by 24
Ronden, R. A., Houben, A. J. H. M., Teerlink, T., Bakker, J. A., Bierau, J., Stehouwer, C. D. A., de Leeuw, P. W., & Kroon, A. A. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00045.2012 · Cited by 22
Hewedy, W. A., & Mostafa, D. K. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.08.009 · Cited by 22
Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients
Perticone, M., Maio, R., Sciacqua, A., Cimellaro, A., Andreucci, M., Tripepi, G. L., Zoccali, C., Sesti, G., & Perticone, F. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.003 · Cited by 19
Self-citationWetzel, M. D., Gao, T., Stanley, K., Cooper, T. K., Morris, S. M., & Awad, A. S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00518.2019 · Cited by 19
Wang, Y., An, W., Zhang, F., Niu, M., Liu, Y. X., & Shi, R. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13001 · Cited by 18
Merino, J., Ferré, R., Girona, J., Aguas, D., Cabré, A., Plana, N., Vinuesa, A. S., Ibarretxe, D., Basora, J., Buixadera, C., et al. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828501c9 · Cited by 16
Pérez‐Aguilar, S., Torres‐Tirado, D., Martel‐Gallegos, G., Velarde‐Salcedo, A. J., de la Rosa, A. P. B., Knabb, M. T., & Rubio, R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00481.2013 · Cited by 12
Zoccali, C., Torino, C., Curatola, G., Panuccio, V. A., Tripepi, R., Pizzini, P., Versace, M., Bolignano, D., Cutrupi, S., Ghiadoni, L., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.008 · Cited by 12
Self-citationBabbitt, D. M., Kim, J.-S., Forrester, S. J., Brown, M. D., & Park, J. (2015) · Ethnicity & Disease · doi:10.18865/ed.25.4.413 · Cited by 11
Tavana, E. N., Sabri, M., Ahmadi, A., & Gheissari, A. (2015) · Advanced Biomedical Research · doi:10.4103/2277-9175.172996 · Cited by 8
Obayashi, K., Kurumatani, N., & Saeki, K. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.07.001 · Cited by 4
Cited by
Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad083 · Cited by 363
Self-citationGlobal, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019
Deng, Y., Li, N., Wu, Y., Wang, M., Yang, S., Zheng, Y., Deng, X., Xiang, D., Zhu, Y., Xu, P., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.672350 · Cited by 319
Ferlazzo, N., Currò, M., Isola, G., Maggio, S., Bertuccio, M. P., Trovato-Salinaro, A., Matarese, G., Alibrandi, A., Caccamo, D., & Ientile, R. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020051 · Cited by 27
Metadata
- Authors
- Roumeliotis, S., Mallamaci, F., & Zoccali, C.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-07-23
- Volume
- 9
- Issue
- 8
- Pages
- 2359
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3044339706
- Cited by
- 284
- References
- 217
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.